» Articles » PMID: 20238057

Investigating the Mechanism of Disease in the RP10 Form of Retinitis Pigmentosa

Overview
Date 2010 Mar 19
PMID 20238057
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Retinitis pigmentosa (RP) is a disease characterized by its vast heterogeneity. Many genes are associated with RP, and the disease causing mutations identified in these genes are even more numerous. To date there are 15 genes that cause autosomal dominant RP (adRP) alone. The role of some of these genes, while complex and not completely understood, is somewhat intuitive in that they are involved in pathways such as phototransduction. However, the role of other genes in retinal disease is not as predictable due to their ubiquitous function and/or expression. One such gene is inosine monophosphate dehydrogenase 1 (IMPDH1) IMPDH1 is a gene involved in de novo purine synthesis and is ubiquitously expressed. IMPDH1 mutations account for 2% of all adRP cases and are a rare cause of Leiber Congenital Amaurosis. Despite its ubiquitous expression missense mutations in this gene cause only retinal degeneration. This paradox of tissue specific disease in the presence of ubiquitous expression has only recently begun to be explained. We have shown in a recent study that novel retinal isoforms of IMPDH1 exist and may account for the tissue specificity of disease. We have gone on to characterize these retinal isoforms both in our laboratory and in collaboration with Dr. Lizbeth Hedstrom's laboratory at Brandeis University (Waltham, MA) in order to understand more about them. We believe that through clarifying the mechanism of disease in RP10 we will be equipped to consider treatment options for this disease.

Citing Articles

Insights on the conformation and appropriate drug-target sites on retinal IMPDH1 using the 604-aa isoform lacking the C-terminal extension.

Elyasi-Ebli P, Yazdanparast R, Gharaghani S, Barzegari E Res Pharm Sci. 2024; 18(6):638-647.

PMID: 39005562 PMC: 11246115. DOI: 10.4103/1735-5362.389951.


The Role of the U5 snRNP in Genetic Disorders and Cancer.

Wood K, Eadsforth M, Newman W, OKeefe R Front Genet. 2021; 12:636620.

PMID: 33584830 PMC: 7876476. DOI: 10.3389/fgene.2021.636620.


Monogenic variants in dystonia: an exome-wide sequencing study.

Zech M, Jech R, Boesch S, Skorvanek M, Weber S, Wagner M Lancet Neurol. 2020; 19(11):908-918.

PMID: 33098801 PMC: 8246240. DOI: 10.1016/S1474-4422(20)30312-4.


The functional impact of the C/N-terminal extensions of the mouse retinal IMPDH1 isoforms: a kinetic evaluation.

Andashti B, Yazdanparast R, Barzegari E, Galehdari H Mol Cell Biochem. 2019; 465(1-2):155-164.

PMID: 31838626 DOI: 10.1007/s11010-019-03675-9.

References
1.
Xu D, Cobb G, Spellicy C, Bowne S, Daiger S, Hedstrom L . Retinal isoforms of inosine 5'-monophosphate dehydrogenase type 1 are poor nucleic acid binding proteins. Arch Biochem Biophys. 2008; 472(2):100-4. PMC: 2366119. DOI: 10.1016/j.abb.2008.02.012. View

2.
Gire A, Sullivan L, Bowne S, Birch D, Hughbanks-Wheaton D, Heckenlively J . The Gly56Arg mutation in NR2E3 accounts for 1-2% of autosomal dominant retinitis pigmentosa. Mol Vis. 2007; 13:1970-5. View

3.
Mortimer S, Xu D, McGrew D, Hamaguchi N, Lim H, Bowne S . IMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNA. J Biol Chem. 2008; 283(52):36354-60. PMC: 2605994. DOI: 10.1074/jbc.M806143200. View

4.
Kennan A, Aherne A, Palfi A, Humphries M, McKee A, Stitt A . Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) mice. Hum Mol Genet. 2002; 11(5):547-57. DOI: 10.1093/hmg/11.5.547. View

5.
Bowne S, Sullivan L, Blanton S, Cepko C, Blackshaw S, Birch D . Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa. Hum Mol Genet. 2002; 11(5):559-68. PMC: 2585828. DOI: 10.1093/hmg/11.5.559. View